Abstract
Emergency contraception (EC) is a method of birth control that is taken after unprotected intercourse. It can be taken when a regular method of contraception is not used or is used incorrectly. EC is particularly important for victims of sexual assault or reproductive coercion. There are three methods of EC available in the USA: oral levonorgestrel, oral ulipristal acetate, and the copper intrauterine device (Cu-IUD). The Cu-IUD is most effective and offers both emergency and ongoing contraception. There are no contraindications to adolescents using EC, and side effects are generally mild. One form of levonorgestrel EC, Plan B One-Step, is now available over-the-counter for women of all ages. Other forms of levonorgestrel EC require a prescription for women younger than 17. Routinely discussing EC, providing timely access to copper IUDs for teens facing contraceptive emergencies, and offering advance prescription for EC are all ways to increase teens’ access to EC. Increased information about and access to EC does not increase teens’ sexual risk-taking behavior.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Morris JM, Van Wagenen G. Compounds interfering with ovum implantation and development 3. The role of estrogens. Am J Obstet Gynecol. 1966;96(6):804–15.
Yuzpe AA, Thurlow HJ, Ramzy I, Leyshon JI. Post coital contraception—a pilot study. J Reprod Med. 1974;13(2):53–8.
Kesseru E, Garmendia F, Westphal N, Parada J. The hormonal and peripheral effects of d-norgestrel in postcoital contraception. Contraception. 1974;10(4):411–24.
First emergency contraceptive product hits U.S. market shelves. Contracept Technol Update. 1998;19(11):141–3.
Lippes J, Malik T, Tatum HJ. The postcoital copper-T. Adv Plan Parent. 1976;11(1):24–9.
Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C. Contraception. 1997;56(6):341–52.
Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation. Lancet. 1998;352(9126):428–33.
von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bartfai G, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet. 2002;360(9348):1803–10.
Glasier A, Cameron ST, Blithe D, Scherrer B, Mathe H, Levy D, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception. 2011;84(4):363–7.
Glasier A, Thong KJ, Dewar M, Mackie M, Baird DT. Postcoital contraception with mifepristone. Lancet. 1991;337(8754):1414–5.
Webb AM. Alternative treatments in oral postcoital contraception: interim results. Adv Contracept. 1991;7(2–3):271–9.
Cheng L, Gulmezoglu AM, Piaggio G, Ezcurra E, Van Look PF. Interventions for emergency contraception. Cochrane Database Syst Rev. 2008;(2):CD001324.
Martinez G, Copen CE, Abma JC. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006–2010 national survey of family growth. Vital Health Stat 23. 2011;31:1–35.
Mosher WD, Jones J. Use of contraception in the United States: 1982–2008. Vital Health Stat 23. 2010;29:1–44.
Sagiroglu N. Phagocytosis of spermatozoa in the uterine cavity of woman using intrauterine device. Int J Fertil. 1971;16(1):1–14.
Ammala M, Nyman T, Strengell L, Rutanen EM. Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium. Fertil Steril. 1995;63(4):773–8.
El-Habashi M, El-Sahwi S, Gawish S, Osman M. Effect of Lippes loop on sperm recovery from human fallopian tubes. Contraception. 1980;22(5):549–55.
Ortiz ME, Croxatto HB, Bardin CW. Mechanisms of action of intrauterine devices. Obstet Gynecol Surv. 1996;51(12 Suppl):S42–51.
Hapangama D, Glasier AF, Baird DT. The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle. Contraception. 2001;63(3):123–9.
Marions L, Cekan SZ, Bygdeman M, Gemzell-Danielsson K. Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function. Contraception. 2004;69(5):373–7.
Durand M, del Carmen Cravioto M, Raymond EG, et al. The mechanism of action of short-term levonorgestrel administration in emergency contraception. Contraception. 2001;64:227–34.
Brache V, Cochon L, Jesam C, Maldonado R, Salvatierra AM, Levy DP, et al. Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. Hum Reprod. 2010;25(9):2256–63.
Stratton P, Levens ED, Hartog B, Piquion J, Wei Q, Merino M, et al. Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914. Fertil Steril. 2010;93(6):2035–41.
Trussell J, Ellertson C, von Hertzen H, Bigrigg A, Webb A, Evans M, et al. Estimating the effectiveness of emergency contraceptive pills. Contraception. 2003;67(4):259–65.
Stirling A, Glasier A. Estimating the efficacy of emergency contraception—how reliable are the data? Contraception. 2002;66(1):19–22.
Raymond E, Taylor D, Trussell J, Steiner MJ. Minimum effectiveness of the levonorgestrel regimen of emergency contraception. Contraception. 2004;69(1):79–81.
Fine P, Mathe H, Ginde S, Cullins V, Morfesis J, Gainer E. Ulipristal acetate taken 48–120 hours after intercourse for emergency contraception. Obstet Gynecol. 2010;115(2 Pt 1):257–63.
Creinin MD, Schlaff W, Archer DF, Wan L, Frezieres R, Thomas M, et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol. 2006;108(5):1089–97.
Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010;375(9714):555–62.
Raine TR, Ricciotti N, Sokoloff A, Brown BA, Hummel A, Harper CC. An over-the-counter simulation study of a single-tablet emergency contraceptive in young females. Obstet Gynecol. 2012;119(4):772–9.
Teal SB, Sheeder J. IUD use in adolescent mothers: retention, failure and reasons for discontinuation. Contraception. 2012;85(3):270–4.
Ho PC, Kwan MS. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum Reprod. 1993;8(3):389–92.
Committee ACOG. Opinion no. 450: Increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet Gynecol. 2009;114(6):1434–8.
Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2012;120:983–8.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 121: long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2011;118(1):184–96.
Brahmi D, Steenland MW, Renner RM, Gaffield ME, Curtis KM. Pregnancy outcomes with an IUD in situ: a systematic review. Contraception. 2012;85(2):131–9.
Zhang L, Chen J, Wang Y, Ren F, Yu W, Cheng L. Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study. Hum Reprod. 2009;24(7):1605–11.
Ghosh B, Dadhwal V, Deka D, Ramesan CK, Mittal S. Ectopic pregnancy following levonorgestrel emergency contraception: a case report. Contraception. 2009;79(2):155–7.
Cabar FR, Pereira PP, Zugaib M. Ectopic pregnancy following levonorgestrel emergency contraception. Contraception. 2009;80(2):227; author reply 227–8.
Kozinszky Z, Bakken RT, Lieng M. Ectopic pregnancy after levonorgestrel emergency contraception. Contraception. 2011;83(3):281–3.
Cleland K, Raymond E, Trussell J, Cheng L, Zhu H. Ectopic pregnancy and emergency contraceptive pills: a systematic review. Obstet Gynecol. 2010;115(6):1263–6.
Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines 2010. MMWR Recomm Rep. 2010;59(RR-12):1–110.
U.S. Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2007;147(2):128–34.
Centers for Disease Control and Prevention. U.S. selected practice recommendations for contraceptive use, 2013. MMWR Recomm Rep. 2013;62(5):1–64.
ella [package insert]. Morristown, NJ: Watson Pharmaceuticals; 2010. http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022474s000lbl.pdf. Accessed 1 Apr 2012.
Miller E, Decker MR, Raj A, Reed E, Marable D, Silverman JG. Intimate partner violence and health care-seeking patterns among female users of urban adolescent clinics. Matern Child Health J. 2010;14(6):910–7.
Wilkinson TA, Fahey N, Suther E, Cabral HJ, Silverstein M. Access to emergency contraception for adolescents. JAMA. 2012;307(4):362–3.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 112: emergency contraception. Obstet Gynecol. 2010;115(5):1100–9.
American Academy of Pediatrics Committee on Adolescence. Emergency contraception. Pediatrics. 2005;116(4):1026–35.
Gold MA, Sucato GS, Conard LA, Hillard PJ. Provision of emergency contraception to adolescents. J Adolesc Health. 2004;35(1):67–70.
Raine TR, Harper CC, Rocca CH, Fischer R, Padian N, Klausner JD, et al. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA. 2005;293(1):54–62.
Gold MA, Wolford JE, Smith KA, Parker AM. The effects of advance provision of emergency contraception on adolescent women’s sexual and contraceptive behaviors. J Pediatr Adolesc Gynecol. 2004;17(2):87–96.
Belzer M, Sanchez K, Olson J, Jacobs AM, Tucker D. Advance supply of emergency contraception: a randomized trial in adolescent mothers. J Pediatr Adolesc Gynecol. 2005;18(5):347–54.
Raymond EG, Stewart F, Weaver M, Monteith C, Van Der Pol B. Impact of increased access to emergency contraceptive pills: a randomized controlled trial. Obstet Gynecol. 2006;108(5):1098–106.
Harper CC, Cheong M, Rocca CH, Darney PD, Raine TR. The effect of increased access to emergency contraception among young adolescents. Obstet Gynecol. 2005;106(3):483–91.
Rocca CH, Schwarz EB, Stewart FH, Darney PD, Raine TR, Harper CC. Beyond access: acceptability, use and nonuse of emergency contraception among young women. Am J Obstet Gynecol. 2007;196(1):29.e1–6; discussion 90.e1–5.
Johnson R, Nshom M, Nye AM, Cohall AT. There’s always Plan B: adolescent knowledge, attitudes and intention to use emergency contraception. Contraception. 2010;81(2):128–32.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rapkin, R.B., Schwarz, E.B. (2014). Emergency Contraception. In: Whitaker, A., Gilliam, M. (eds) Contraception for Adolescent and Young Adult Women. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6579-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6579-9_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6578-2
Online ISBN: 978-1-4614-6579-9
eBook Packages: MedicineMedicine (R0)